You're so right - there is no cause for concern. Most are holding from the $2 - $3 range, and are sitting on fabulous returns.
A re-rating in the $4 - $5 range is a 100% return. That's fair-value for a compound entering Phase III trials.
Anything over $5 is clearly overvalued at this point. The potential revenue of this drug - given that it is even approved - is being overstated.
- Forums
- ASX - By Stock
- PGL
- looking sick
looking sick, page-4
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PGL (ASX) to my watchlist
|
|||||
Last
44.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.30M |
Open | High | Low | Value | Volume |
44.5¢ | 45.0¢ | 44.5¢ | $157.9K | 353.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 303346 | 44.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 246671 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 418554 | 0.445 |
7 | 911759 | 0.440 |
3 | 8500 | 0.350 |
1 | 2500 | 0.200 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.450 | 243226 | 10 |
0.460 | 100000 | 1 |
0.490 | 21811 | 2 |
0.500 | 2000 | 1 |
0.590 | 292887 | 2 |
Last trade - 15.32pm 24/07/2024 (20 minute delay) ? |
Featured News
PGL (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
Previous Video
Next Video
SPONSORED BY The Market Online